CN103505633B - Traditional Chinese medicine composition for treating osteomyelitis - Google Patents

Traditional Chinese medicine composition for treating osteomyelitis Download PDF

Info

Publication number
CN103505633B
CN103505633B CN201310387534.XA CN201310387534A CN103505633B CN 103505633 B CN103505633 B CN 103505633B CN 201310387534 A CN201310387534 A CN 201310387534A CN 103505633 B CN103505633 B CN 103505633B
Authority
CN
China
Prior art keywords
parts
radix
herba
chinese medicine
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310387534.XA
Other languages
Chinese (zh)
Other versions
CN103505633A (en
Inventor
宋景戈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuyuan Bencao Shandong Health Technology Co ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310387534.XA priority Critical patent/CN103505633B/en
Publication of CN103505633A publication Critical patent/CN103505633A/en
Application granted granted Critical
Publication of CN103505633B publication Critical patent/CN103505633B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A disclosed traditional Chinese medicine composition for treating osteomyelitis comprises the raw materials in parts by weight: 3-5 parts of coptis, 13-15 parts of radix scutellariae, 5-10 parts of raw rhubarb, 3-5 parts of radix astragali, 2-4 parts of ginseng, 7-9 parts of grape root, 3-5 parts of semiaquilegia root, 7-9 parts of motherwort, 3-5 parts of sappan wood, 2-5 parts of medicated leaven, 8-10 parts of viola yedoensis makino, 3-5 parts of semiaquilegia root, 2-4 parts of dioscorea bulbifera, 5-8 parts of viola concordifolia, 8-10 parts of semen cuscutae, 3-5 parts of Chinese scholar tree leave, 2-4 parts of artemisia japonica, 5-8 parts of anemone vitifolia, 2-4 parts of verbena, 8-10 parts of herba ophioglossi and 1-3 parts of sweet potato seed. The traditional Chinese medicine composition is capable of clearing heat, detoxifying, dispersing abscesses and nodules, freeing the collateral vessels, relieving pain, dispelling stasis to promote regeneration, promoting wound healing rapidly, regulating and nourishing qi and blood, reinforcing the healthy qi and eliminating the pathogenic factors, increasing essence, supplementing marrow and promoting generation of new bone, and is none in toxic and side effects, short in treatment course and good in treatment effect on osteomyelitis.

Description

One treats myelitic Chinese medicine composition
Technical field
The present invention relates to one and treat myelitic Chinese medicine composition, belong to the field of Chinese medicines.
Background technology
The diseases associated with inflammation that osteomyelitis refers to suppurative bacterium infection bone marrow, cortical bone and periosteum and causes, majority is caused by haematogenous, also how to be caused by wound or postoperative infection, how to enter blood by suppuration bacterium and to reach osseous tissue, bones of limbs two ends are subject to invade most, are the most common especially with hip joint; The normal threat to life of patient with severe symptoms, the emergency approach taking amputation to save one's life of sometimes having to, but fall lifelong disability, and also surgery cost is expensive, causes suffering to patient and family; At present, it is more to treat myelitic Chinese medicine kind, but ubiquity curative effect is poor, and healing time is long, the problem that patient suffering is large.
Summary of the invention
One is the object of the present invention is to provide to treat myelitic Chinese medicine composition.
The present invention adopts following technical scheme:
Treat myelitic Chinese medicine, the weight portion of its constitutive material is: Rhizoma Coptidis 3-5, Radix Scutellariae 13-15, Radix Et Rhizoma Rhei 5-10, Radix Astragali 3-5, Radix Ginseng 2-4, Radix vitis viniferae 7-9, Radix Semiaquilegiae 3-5, Herba Leonuri 7-9, Lignum Sappan 3-5, Massa Medicata Fermentata 2-5, Herba Violae 8-10, Radix Semiaquilegiae 3-5, Pseudobulbus cremastrae seu pleiones 2-4, Herba Violae japonicae 5-8, Semen Cuscutae 8-10, Folium sophorae 3-5, Herba Artemisiae Japonicae 2-4, Herba anemones vitifoliae 5-8, Herba Verbenae 2-4, Herba Ophioglossi 8-10 and Radix Ipomoeae 1-3.
Treat myelitic Chinese medicine, the weight portion of its constitutive material is: Rhizoma Coptidis 4, Radix Scutellariae 14, Radix Et Rhizoma Rhei 8, the Radix Astragali 4, Radix Ginseng 3, Radix vitis viniferae 8, Radix Semiaquilegiae 4, Herba Leonuri 8, Lignum Sappan 4, Massa Medicata Fermentata 3.5, Herba Violae 9, Radix Semiaquilegiae 4, Pseudobulbus cremastrae seu pleiones 3, Herba Violae japonicae 6.5, Semen Cuscutae 9, Folium sophorae 4, Herba Artemisiae Japonicae 3, Herba anemones vitifoliae 6.5, Herba Verbenae 3, Herba Ophioglossi 9 and Radix Ipomoeae 2.
Method of preparation and use: take each raw material by the weight portion of constitutive material, grind, sieve, adds appropriate water mix homogeneously, under being coated on affected part outward, once a day.
Beneficial effect of the present invention:
Heat-clearing and toxic substances removing of the present invention, eliminating carbuncle eliminating stagnation, removing obstruction in the collateral to relieve pain, promoting tissue regeneration by removing blood stasis, closes up fast, and energy compensate qi and blood, strengthening vital QI to eliminate pathogenic factors, add essence and mend marrow, promote the generation of new bone, the present invention has no side effect, short treating period, has good therapeutic effect to osteomyelitis.
Detailed description of the invention
Embodiment 1: treat myelitic Chinese medicine composition, the weight portion (g) of its constitutive material is: Rhizoma Coptidis 4, Radix Scutellariae 14, Radix Et Rhizoma Rhei 8, the Radix Astragali 4, Radix Ginseng 3, Radix vitis viniferae 8, Radix Semiaquilegiae 4, Herba Leonuri 8, Lignum Sappan 4, Massa Medicata Fermentata 3.5, Herba Violae 9, Radix Semiaquilegiae 4, Pseudobulbus cremastrae seu pleiones 3, Herba Violae japonicae 6.5, Semen Cuscutae 9, Folium sophorae 4, Herba Artemisiae Japonicae 3, Herba anemones vitifoliae 6.5, Herba Verbenae 3, Herba Ophioglossi 9 and Radix Ipomoeae 2.
Method of preparation and use: take each raw material by the weight portion of constitutive material, grind, sieve, adds appropriate water mix homogeneously, under being coated on affected part outward, once a day.
Model case:
Case 1: wish certain, man, 63 years old, right knee joint swelled and ache, difficulty in walking, generated heat or felt cold, local is red and swollen, suffers from osteomyelitis on inspection, applies Chinese medicine of the present invention, and once a day, coating after two months, arthralgia obviously alleviates, and still can walk, and continues coating three months, radical cure, without recurrence.
Case 2: thank certain, man, 74 years old, suffer from more than 10 years of osteomyelitis, leg joint swelled and ache, and heating, applies Chinese medicine of the present invention, and once a day, after two months, arthralgia obviously alleviates in coating, continues coating one the consolidate curative effect course for the treatment of, radical cure, painless.
Case 3: fourth, man, 72 years old, suffer from more than 10 years of osteomyelitis, leg joint swelled and ache, rear coating Chinese medicine of the present invention, and once a day, apply after one month, arthralgia obviously alleviates, and continuation coating is effected a radical cure with consolidate curative effect for two months.

Claims (2)

1. treat a myelitic Chinese medicine, it is characterized in that the weight portion of its constitutive material is: Rhizoma Coptidis 3-5, Radix Scutellariae 13-15, Radix Et Rhizoma Rhei 5-10, Radix Astragali 3-5, Radix Ginseng 2-4, Radix vitis viniferae 7-9, Radix Semiaquilegiae 3-5, Herba Leonuri 7-9, Lignum Sappan 3-5, Massa Medicata Fermentata 2-5, Herba Violae 8-10, Radix Semiaquilegiae 3-5, Pseudobulbus cremastrae seu pleiones 2-4, Herba Violae japonicae 5-8, Semen Cuscutae 8-10, Folium sophorae 3-5, Herba Artemisiae Japonicae 2-4, Herba anemones vitifoliae 5-8, Herba Verbenae 2-4, Herba Ophioglossi 8-10 and Radix Ipomoeae 1-3.
2. the myelitic Chinese medicine for the treatment of according to claim 1, is characterized in that the weight portion of its constitutive material is: Rhizoma Coptidis 4, Radix Scutellariae 14, Radix Et Rhizoma Rhei 8, the Radix Astragali 4, Radix Ginseng 3, Radix vitis viniferae 8, Radix Semiaquilegiae 4, Herba Leonuri 8, Lignum Sappan 4, Massa Medicata Fermentata 3.5, Herba Violae 9, Radix Semiaquilegiae 4, Pseudobulbus cremastrae seu pleiones 3, Herba Violae japonicae 6.5, Semen Cuscutae 9, Folium sophorae 4, Herba Artemisiae Japonicae 3, Herba anemones vitifoliae 6.5, Herba Verbenae 3, Herba Ophioglossi 9 and Radix Ipomoeae 2.
CN201310387534.XA 2013-08-31 2013-08-31 Traditional Chinese medicine composition for treating osteomyelitis Active CN103505633B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310387534.XA CN103505633B (en) 2013-08-31 2013-08-31 Traditional Chinese medicine composition for treating osteomyelitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310387534.XA CN103505633B (en) 2013-08-31 2013-08-31 Traditional Chinese medicine composition for treating osteomyelitis

Publications (2)

Publication Number Publication Date
CN103505633A CN103505633A (en) 2014-01-15
CN103505633B true CN103505633B (en) 2015-06-17

Family

ID=49889406

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310387534.XA Active CN103505633B (en) 2013-08-31 2013-08-31 Traditional Chinese medicine composition for treating osteomyelitis

Country Status (1)

Country Link
CN (1) CN103505633B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106421181A (en) * 2016-12-07 2017-02-22 李昭 Osteomyelitis powder cream

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1840034A (en) * 2006-01-12 2006-10-04 李其全 Medicine for treating acute hematogenous osteomyelitis and preparation method thereof
CN102085315A (en) * 2011-01-02 2011-06-08 江和训 Traditional Chinese medicine composition for treating acute and chronic osteomyelitis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1840034A (en) * 2006-01-12 2006-10-04 李其全 Medicine for treating acute hematogenous osteomyelitis and preparation method thereof
CN102085315A (en) * 2011-01-02 2011-06-08 江和训 Traditional Chinese medicine composition for treating acute and chronic osteomyelitis

Also Published As

Publication number Publication date
CN103505633A (en) 2014-01-15

Similar Documents

Publication Publication Date Title
CN101234153B (en) Externally-applied medicament for treating bone fracture
CN101417003A (en) Traditional Chinese medicine composition for treating vertebras disease
CN103505633B (en) Traditional Chinese medicine composition for treating osteomyelitis
CN1294940C (en) Chinese medicinal preparation for treating rheumatic and homologus rheumatic artbritis
CN103751427B (en) A kind of precious jade medicine treating radius far-end fracture
CN1478525A (en) Medicated wine for treating traumatic injury
CN101647865B (en) Externally-applied medicine for treating traumatic injuries
CN103977308A (en) Tradition Chinese medicine composition for treating ankylosing spondylitis
CN100522215C (en) Traditional Chinese medicine composition for treating traumatic injury and bone fracture
CN103432297B (en) Traditional Chinese medicine for treating osteomyelitis
CN102920953A (en) Traditional Chinese medicine composition for treating nonunion of postoperative cut
CN104800443A (en) Bone setting agent with functions of tonifying kidney and regenerating bone marrow
CN100364603C (en) Externally used Chinese herbal medicinal composition
CN104367679A (en) Traditional Chinese medicine composition ointment for treating rheumatism and bone diseases
CN103990067B (en) External used medicine for the treatment of prolapse of lumbar intervertebral disc and preparation method thereof
CN108888736B (en) External-use bone reunion medicine and preparation method thereof
CN103099889B (en) Traditional Chinese medicine wine for treating lumbar spinal stenosis
CN102908585B (en) One treats sciatica Chinese medicine
CN101954043A (en) Medicament for treating hyperosteogeny and preparation method thereof
CN1279958A (en) Medicine for curing osteomyelitis and its preparing method
CN104435815A (en) Externally-applied traditional Chinese medicine for treating adhesive capsulitis of shoulders
CN103977282A (en) Cordyceps sinensis traditional Chinese medicine preparation for promoting fracture healing
CN104383205A (en) Muscle relaxing and blood circulation stimulating medicine liquor externally used for treating orthopedic diseases
CN104922443A (en) External-use patch for treating rheumatic arthritis
CN111467395A (en) Ointment for promoting blood circulation and dredging channels and collaterals

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20211213

Address after: 250100 room 2-401, No. 51, Gongye South Road, Gongxin District, Jinan City, Shandong Province

Patentee after: JINAN XINGYI MEDICAL TECHNOLOGY Co.,Ltd.

Address before: 236300 Red Cross Hospital of Funan County, Fuyang City, Anhui Province

Patentee before: Song Jingge

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20220913

Address after: 255000 room 1312, main building, scientific research center, biomedical park, No. 1, Lutai Avenue, high tech Zone, Zibo City, Shandong Province

Patentee after: Wuyuan Bencao (Shandong) Health Technology Co.,Ltd.

Address before: 250100 room 2-401, No. 51, Gongye South Road, Gongxin District, Jinan City, Shandong Province

Patentee before: JINAN XINGYI MEDICAL TECHNOLOGY Co.,Ltd.

TR01 Transfer of patent right